Literature DB >> 15071423

Epidemiology of herpes and HIV co-infection.

Ellie Freedman1, Adrian Mindel.   

Abstract

Most HIV infections are transmitted sexually, particularly in sub-Saharan Africa and Asia. In this article we review various strands of epidemiological evidence linking herpes simplex virus type 2 (HSV-2) and HIV. This includes a consideration of the similarity of the sexual risk factors and behaviours associated with acquisition of these two infections (younger age at coitarche, higher number of sexual partners, women at greater risk than men, homosexual males at greater risk than heterosexual males, previous sexually transmitted infections (STIs), a greater number of years of sexual activity and contact with female sex workers), studies looking at the prevalence and incidence of these infections in the general population and also in populations at increased risk for HIV acquisition, studies showing that HSV-2 is acquired before HIV and finally that individuals with pre-existing HSV-2 are more likely to acquire HIV and that the prevalence of HSV-2 infection in the general population has a major impact on the sexual transmission of HIV. Cohort and nested case-control studies provided information about pre-existing HSV-2 and HIV acquisition and the relative risk (RR) ratio was 2.1 (95% confidence interval, 1.4-3.2). By using this estimate, it has been calculated that in HSV-2-positive individuals, 52% of sexually transmitted risk can be attributed to HSV-2. In addition, the calculated population-attributable risk percentage (also know as the aetiological fraction) varied with the HSV-2 seroprevalence in the population. In populations where HSV-2 prevalence is 80% or more, almost half of the sexually acquired HIV can be attributed to HSV-2.

Entities:  

Mesh:

Year:  2004        PMID: 15071423

Source DB:  PubMed          Journal:  J HIV Ther        ISSN: 1462-0308


  8 in total

1.  Herpes simplex virus type 2 associated with HIV infection among New York heterosexuals living in high-risk areas.

Authors:  H Hagan; S M Jenness; T Wendel; C R Murrill; A Neaigus; C Gelpi-Acosta
Journal:  Int J STD AIDS       Date:  2010-08       Impact factor: 1.359

2.  Sequence variability in clinical and laboratory isolates of herpes simplex virus 1 reveals new mutations.

Authors:  Moriah L Szpara; Lance Parsons; L W Enquist
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

3.  Gender and age disparities in the prevalence of Chlamydia infection among sexually active adults in the United States.

Authors:  Hind A Beydoun; Jessica Dail; Hala Tamim; Bethrand Ugwu; May A Beydoun
Journal:  J Womens Health (Larchmt)       Date:  2010-10-15       Impact factor: 2.681

4.  A case-control study of factors associated with HIV infection among black women.

Authors:  Fatu M Forna; Lisa Fitzpatrick; Adaora A Adimora; Eleanor McLellan-Lemal; Peter Leone; John T Brooks; Gary Marks; Alan Greenberg
Journal:  J Natl Med Assoc       Date:  2006-11       Impact factor: 1.798

5.  Risk factors associated with low CD4+ lymphocyte count among HIV-positive pregnant women in Nigeria.

Authors:  Alash'le Abimiku; Pacha Villalba-Diebold; Jelpe Dadik; Felicia Okolo; Edwina Mang; Man Charurat
Journal:  Int J Gynaecol Obstet       Date:  2009-05-22       Impact factor: 3.561

6.  Community-based prevention leads to an increase in condom use and a reduction in sexually transmitted infections (STIs) among men who have sex with men (MSM) and female sex workers (FSW): the Frontiers Prevention Project (FPP) evaluation results.

Authors:  Juan-Pablo Gutierrez; Sam McPherson; Ade Fakoya; Alexander Matheou; Stefano M Bertozzi
Journal:  BMC Public Health       Date:  2010-08-18       Impact factor: 3.295

7.  Using geospatial modelling to optimize the rollout of antiretroviral-based pre-exposure HIV interventions in Sub-Saharan Africa.

Authors:  David J Gerberry; Bradley G Wagner; J Gerardo Garcia-Lerma; Walid Heneine; Sally Blower
Journal:  Nat Commun       Date:  2014-12-02       Impact factor: 14.919

Review 8.  Developing animal models for polymicrobial diseases.

Authors:  Lauren O Bakaletz
Journal:  Nat Rev Microbiol       Date:  2004-07       Impact factor: 60.633

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.